Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Knipp

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Annals of Hematology|November 5, 2005
Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemiaAndrea Kuendgen, Sabine Knipp, Frank Fox, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 7, 2025
Design of CellProfiler-based Pipelines Enabling the Attribution of Molecular Stress Markers to Specific Tissue and Subcellular Compartments of the Colonic MucosaHelena Hödlmayr, Christina Watschinger, Gerald K Wallner, et al.
Leukemia Research|April 7, 2007
Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcomeSabine Knipp, Corinna Strupp, Norbert Gattermann, et al.
Haematologica|December 6, 2006
Prospective validation of the WHO proposals for the classification of myelodysplastic syndromesUlrich Germing, Corinna Strupp, Andrea Kuendgen, et al.
Cancer|December 3, 2005
The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemiaAndrea Kuendgen, Mathias Schmid, Richard Schlenk, et al.
British Journal of Haematology|September 19, 2006
Exisulind induces apoptosis in advanced myelodysplastic syndrome (MDS) and acute myeloid leukaemia/MDSAkos Czibere, Wolf C Prall, Luiz F Zerbini, et al.
Haematologica|July 4, 2007
Chronic myelomonocytic leukemia in the light of the WHO proposalsUlrich Germing, Corinna Strupp, Sabine Knipp, et al.
Heliyon|August 21, 2024
Affinity purification mass spectrometry characterisation of the interactome of receptor tyrosine kinase proline-rich motifs in cancerChristopher M Jones, Arndt Rohwedder, Kin Man Suen, et al.
Interface Focus|March 21, 2020
A novel workflow for three-dimensional analysis of tumour cell migrationSophie Ketchen, Arndt Rohwedder, Sabine Knipp, et al.
Blood|June 24, 2005
Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromesAkira Matsuda, Ulrich Germing, Itsuro Jinnai, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Annals of Hematology|November 5, 2005
Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemiaAndrea Kuendgen, Sabine Knipp, Frank Fox, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 7, 2025
Design of CellProfiler-based Pipelines Enabling the Attribution of Molecular Stress Markers to Specific Tissue and Subcellular Compartments of the Colonic MucosaHelena Hödlmayr, Christina Watschinger, Gerald K Wallner, et al.
Leukemia Research|April 7, 2007
Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcomeSabine Knipp, Corinna Strupp, Norbert Gattermann, et al.
Haematologica|December 6, 2006
Prospective validation of the WHO proposals for the classification of myelodysplastic syndromesUlrich Germing, Corinna Strupp, Andrea Kuendgen, et al.
Cancer|December 3, 2005
The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemiaAndrea Kuendgen, Mathias Schmid, Richard Schlenk, et al.
British Journal of Haematology|September 19, 2006
Exisulind induces apoptosis in advanced myelodysplastic syndrome (MDS) and acute myeloid leukaemia/MDSAkos Czibere, Wolf C Prall, Luiz F Zerbini, et al.
Haematologica|July 4, 2007
Chronic myelomonocytic leukemia in the light of the WHO proposalsUlrich Germing, Corinna Strupp, Sabine Knipp, et al.
Heliyon|August 21, 2024
Affinity purification mass spectrometry characterisation of the interactome of receptor tyrosine kinase proline-rich motifs in cancerChristopher M Jones, Arndt Rohwedder, Kin Man Suen, et al.
Interface Focus|March 21, 2020
A novel workflow for three-dimensional analysis of tumour cell migrationSophie Ketchen, Arndt Rohwedder, Sabine Knipp, et al.
Blood|June 24, 2005
Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromesAkira Matsuda, Ulrich Germing, Itsuro Jinnai, et al.
Pageof 3